James D. Gustafson

68 year

Health Technology

Profile

James D.
Gustafson has been Senior Vice President-Clinical Evaluation, Research and Development and Chief Quality Officer since August 2005.
Previously, he was Vice President-Quality Assurance, Regulatory and Clinical Affairs.

Former positions of James D. Gustafson

Companies	Position	End
Possis Medical, Inc. Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN.	Chief Tech/Sci/R&D Officer	10/04/2011

See the detail of James D. Gustafson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James D. Gustafson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Possis Medical, Inc. Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN.	Health Technology